Lewy body dementia
Cortical α-synuclein (Lewy body) deposition
Overview
A dementia defined by the triad of FLUCTUATING cognition, recurrent VISUAL HALLUCINATIONS and spontaneous PARKINSONISM, with REM sleep behaviour disorder. Crucially, patients have severe SENSITIVITY to antipsychotics — a key safety point.
Recognise
- Fluctuating cognition/attention, recurrent well-formed visual hallucinations, parkinsonism
- REM sleep behaviour disorder (acting out dreams), autonomic dysfunction, recurrent falls
- Dementia within ~1 year of parkinsonism (vs Parkinson disease dementia which comes years later)
Red flags
- NEUROLEPTIC SENSITIVITY — antipsychotics can cause severe rigidity/irreversible deterioration; recurrent falls
Differentials & how to tell them apart
Investigations
Clinical (consensus criteria); DaTscan (reduced striatal dopamine uptake) supports it; MRI relatively preserves the hippocampus (vs AD).
Management
Cholinesterase inhibitor (rivastigmine/donepezil); AVOID antipsychotics
- 1Cholinesterase inhibitor for cognition and hallucinations; non-drug management of behaviour and falls.Gate: AVOID antipsychotics — neuroleptic sensitivity can cause severe, sometimes irreversible parkinsonism/deterioration; if unavoidable use low-dose quetiapine cautiously
- 2Cautious levodopa for disabling motor symptoms (can worsen hallucinations); treat REM sleep behaviour and autonomic symptoms.
Key points
Fluctuation + visual hallucinations + parkinsonism = Lewy body. The "1-year rule" separates it from Parkinson disease dementia. Antipsychotic sensitivity is the exam safety point.
Monitor & prognosis
Cognition, hallucinations, parkinsonism, falls, drug tolerance.
Progressive; faster decline than Alzheimer.
Source: NICE NG97 (dementia)